Short description
InMed Pharmaceuticals is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates.
Description
InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol ("CBN") in diseases with high unmet medical needs.
The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines.
InMed Pharmaceuticals was established in 1981 in Vancouver, Columbia by Chris Bogart.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Vancouver, British Columbia, Canada, North America
Founded on
January 1, 1981
Exited on
March 29, 2012
Went public on
March 29, 2012
Stock symbol
INM
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Nopepepe
Sign in for full access
Founders
Chris Bogart